BD Names Bridget Bagnato Worldwide President of Peripheral Intervention

FRANKLIN LAKES, N.J., Nov. 4, 2026 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Bridget Bagnato has been appointed worldwide president of its Peripheral Intervention business unit, effective November 16.

Based at Peripheral Intervention’s headquarters in Tempe, Arizona, Bagnato will be responsible for driving the business unit’s global strategic, operational and commercial performance. She will report to Peter Menziuso, executive vice president and president of the Interventional segment.Continue reading→

University of Arizona Center for Innovation Startups Generate $260 Million in Economic Impact, Fueling Arizona’s Economy

November 9, 2026 (Tucson, Ariz.)- Startups supported by the University of Arizona Center for Innovation (UACI) generated an economic output of $260.5 million in 2025, according to a recent economic impact study conducted by Stiletto Consulting, an international market research and strategic planning firm.

 

As part of Tech Parks Arizona, a not-for-profit organization advancing university-based economic development, UACI serves as Arizona’s leading science and tech incubator. Together, Tech Parks Arizona and UACI connect startups and tech giants with the University of Arizona’s world-class research, talent and resources, creating a purpose-built environment.  UACI has supported over 300 companies by connecting them with the people, place, and programming needed to bring ideas from concept to market.

 

The annual study reinforces UACI’s role as a powerful economic engine, noting that the startup clients generated $94.4 million in revenue and secured $10.3 million in grants in 2025. Collectively, these companies supported 1,218 jobs and contributed $21.5 million in tax revenue, demonstrating how innovation commercialized creates lasting economic value for Arizona.

 

“At UACI, the metrics that are important to us are not only the breakthroughs achieved by individual startups, but also the broader impact those innovations have on Arizona’s economy and communities,” said Casey Carrillo, Chief Innovation Officer for UACI. “These results demonstrate how supporting entrepreneurs and emerging technologies create jobs, attract investment and strengthen Arizona’s innovation ecosystem.”

 

UACI also garnered national recognition earlier this year, when TIME Magazine named UACI among America’s Best Incubator and Accelerators for 2026, recognizing its role in helping science and tech startups launch, scale, and create measurable economic impact.

 

UACI maintains an active portfolio of approximately 45-50 startup companies with a high concentration in the bioscience sector. Approximately one-third of client companies are developing innovations in biotechnology, healthcare, diagnostics and medical devices. Together, these startups are helping drive economic growth while advancing technologies that improve lives and have potential for global impact. Recognizing the unique needs of these ventures, UACI has made targeted investments in specialized support services, including affordable rent-a-bench laboratory space, Good Laboratory Practice (GLP) certification, expert guidance from an on-site lab manager, and access to shared scientific equipment. These resources help early-stage bioscience companies accelerate research and development while reducing the barriers and costs often associated with bringing breakthrough technologies to market.

 

“Innovation districts thrive when great ideas, talent and opportunity converge,” said Carol Stewart, CEO & President of Tech Parks Arizona. “Tech Parks Arizona’s recent recognition as a top ranked innovation district in the US reflects the strength of the collaborative ecosystem, we have cultivated to help innovators succeed. The economic impact generated by UACI startups demonstrates the long-term value of investing in innovation and entrepreneurship.”

 

Since 2003, UACI has supported startups across industries including life sciences, climate technology, aerospace, software, advanced manufacturing and engineering. Through mentorship, educational programming, networking opportunities and specialized facilities, UACI continues to help entrepreneurs build thriving companies that contribute to Arizona’s long-term economic growth.

 

About the UA Center for Innovation

The University of Arizona Center for Innovation (UACI) is a startup incubator network with outposts across Southern Arizona. As part of Tech Parks Arizona, a not-for-profit, UACI advances university-based economic impact by helping scale science and tech-based startups, supporting business retention, and attracting foreign direct investment to the region. In 2026, TIME Magazine named UACI among America’s Best Incubators & Accelerators. For two decades, the program has directly served over 300 companies, impacting thousands of entrepreneurs who have attracted more than $200M in external capital. This is done by providing access to the people, place, and programming that help entrepreneurs take their ideas from concept to market.

 

Arizona Bioscience on the Rise: Highlights from the 2026 TEConomy/BIO Report

Arizona’s bioscience industry isn’t just growing. It’s outpacing the nation.

The 2026 edition of The U.S. Bioscience Economy from TEConomy Partners and the Biotechnology Innovation Organization (BIO) gives us a fresh look at how Arizona stacks up. The short version: since 2021, our bioscience workforce has grown 13.4 percent, nearly twice the national rate of 7.0 percent. Here’s what’s driving that momentum.Continue reading→

BD Advances Portal Hypertension Care in the U.S. with Support for More Personalized Treatment Options

Oct. 28, 2026 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. commercial launch of the BD® Liverty™ TIPS Stent Graft, advancing portal hypertension care by giving physicians greater flexibility to tailor treatment to each patient’s hemodynamic needs. The next generation transjugular intrahepatic portosystemic shunt (TIPS) system is designed to provide physicians with deployment accuracy and control, and the flexibility to tailor treatment based on individual patient anatomy, disease progression and clinical goals. The product enters the U.S. market with established clinical and physician experience in Europe and is supported by the six-month interim results from the 177 patient, prospective, multi-center ARCH clinical study, the first and only IDE study with small TIPS diameter (6-7 mm) clinical data.Continue reading→

Treasury Issues Proposed Rule to Implement Comprehensive Outbound Investment National Security Act

WASHINGTON– The U.S. Department of the Treasury (Treasury) today issued a Notice of Proposed Rulemaking (NPRM) to propose updates to the Outbound Investment Security Program (OISP) based on direction from Congress in the Comprehensive Outbound Investment Security (COINS) Act, passed as part of the Fiscal Year 2026 National Defense Authorization Act.  The COINS Act codifies the U.S. Government’s approach to regulating certain outbound investments by U.S. persons and builds upon Treasury’s existing OISP. 

Continue reading→